Psoriasis and Psoriatic Arthritis
Psoriasis with psoriatic arthritis is a chronic and difficult-to-treat inflammatory skin condition. Recent developments in biology, immunology, and molecular biology have enabled us to use various targeted therapeutics in treating these conditions, such as biologics and small-molecule inhibitors. Th...
Sábháilte in:
| Formáid: | Online |
|---|---|
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
MDPI - Multidisciplinary Digital Publishing Institute
2025
|
| Ábhair: | |
| Rochtain ar líne: | ONIX_20250220_9783725818792_39 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
| _version_ | 1869515506687410176 |
|---|---|
| collection | Directory of Open Access Books |
| description | Psoriasis with psoriatic arthritis is a chronic and difficult-to-treat inflammatory skin condition. Recent developments in biology, immunology, and molecular biology have enabled us to use various targeted therapeutics in treating these conditions, such as biologics and small-molecule inhibitors. The enhanced speed at which translational research is developing in this field has led to the production of many biologics technologies and small-molecule inhibitors, but a complete cure for this condition has not yet been accomplished. In light of this, understanding the pathophysiology of these conditions is crucial and would allow us to carefully recognize which patients need to be treated earlier in order to improve patients’ quality of life. This Special Issue is composed of discussions on the pathophysiology of psoriasis with psoriatic arthritis, including infiltrating effector T-cells, regulatory T-cells, dendritic cells, monocytes, and macrophages; the treatment of psoriasis with psoriatic arthritis, including biologics, small-molecule inhibitors, and topical treatments; and the quality of life of patients with this condition, which includes the introduction of treatment goals and the treat-to-target concept. |
| format | Online |
| id | doab-20.500.12854ir-152675 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1526752025-02-20T12:53:38Z Psoriasis and Psoriatic Arthritis Komine, Mayumi psoriasis COVID-19 SARS-CoV-2 systemic therapy biologics inflammatory skin disease Th17 cells adipokines glycoproteins fatty acid-binding protein skin-resident memory T cells human cytokines autoantigens treatment regulatory T cell forkhead box protein 3 short chain fatty acid butyrate interleukin-17A interleukin-23 dendritic cell gut microbiome Janus kinases therapy calcipotriol betamethasone dipropionate long-term treatment nail psoriasis proactive treatment topical therapy scalp psoriasis vitamin D3 derivatives BMDCs IL-23 IL-36γ metformin psoriatic arthritis assessment disease activity composite disease activity measures patient-reported outcomes cross-sectional studies health care surveys Japan treatment goal biological drugs anti-TNF-α anti-IL-17 anti-IL-12/23 adherence persistence early diagnosis early intervention female sex hormone estrogen progesterone thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MN Surgery Psoriasis with psoriatic arthritis is a chronic and difficult-to-treat inflammatory skin condition. Recent developments in biology, immunology, and molecular biology have enabled us to use various targeted therapeutics in treating these conditions, such as biologics and small-molecule inhibitors. The enhanced speed at which translational research is developing in this field has led to the production of many biologics technologies and small-molecule inhibitors, but a complete cure for this condition has not yet been accomplished. In light of this, understanding the pathophysiology of these conditions is crucial and would allow us to carefully recognize which patients need to be treated earlier in order to improve patients’ quality of life. This Special Issue is composed of discussions on the pathophysiology of psoriasis with psoriatic arthritis, including infiltrating effector T-cells, regulatory T-cells, dendritic cells, monocytes, and macrophages; the treatment of psoriasis with psoriatic arthritis, including biologics, small-molecule inhibitors, and topical treatments; and the quality of life of patients with this condition, which includes the introduction of treatment goals and the treat-to-target concept. 2025-02-20T12:53:35Z 2025-02-20T12:53:35Z 2024 book ONIX_20250220_9783725818792_39 9783725818792 9783725818808 https://directory.doabooks.org/handle/20.500.12854/152675 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/9794 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-1880-8 10.3390/books978-3-7258-1880-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725818792 9783725818808 166 Basel open access |
| spellingShingle | psoriasis COVID-19 SARS-CoV-2 systemic therapy biologics inflammatory skin disease Th17 cells adipokines glycoproteins fatty acid-binding protein skin-resident memory T cells human cytokines autoantigens treatment regulatory T cell forkhead box protein 3 short chain fatty acid butyrate interleukin-17A interleukin-23 dendritic cell gut microbiome Janus kinases therapy calcipotriol betamethasone dipropionate long-term treatment nail psoriasis proactive treatment topical therapy scalp psoriasis vitamin D3 derivatives BMDCs IL-23 IL-36γ metformin psoriatic arthritis assessment disease activity composite disease activity measures patient-reported outcomes cross-sectional studies health care surveys Japan treatment goal biological drugs anti-TNF-α anti-IL-17 anti-IL-12/23 adherence persistence early diagnosis early intervention female sex hormone estrogen progesterone thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MN Surgery Psoriasis and Psoriatic Arthritis |
| title | Psoriasis and Psoriatic Arthritis |
| title_full | Psoriasis and Psoriatic Arthritis |
| title_fullStr | Psoriasis and Psoriatic Arthritis |
| title_full_unstemmed | Psoriasis and Psoriatic Arthritis |
| title_short | Psoriasis and Psoriatic Arthritis |
| title_sort | psoriasis and psoriatic arthritis |
| topic | psoriasis COVID-19 SARS-CoV-2 systemic therapy biologics inflammatory skin disease Th17 cells adipokines glycoproteins fatty acid-binding protein skin-resident memory T cells human cytokines autoantigens treatment regulatory T cell forkhead box protein 3 short chain fatty acid butyrate interleukin-17A interleukin-23 dendritic cell gut microbiome Janus kinases therapy calcipotriol betamethasone dipropionate long-term treatment nail psoriasis proactive treatment topical therapy scalp psoriasis vitamin D3 derivatives BMDCs IL-23 IL-36γ metformin psoriatic arthritis assessment disease activity composite disease activity measures patient-reported outcomes cross-sectional studies health care surveys Japan treatment goal biological drugs anti-TNF-α anti-IL-17 anti-IL-12/23 adherence persistence early diagnosis early intervention female sex hormone estrogen progesterone thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MN Surgery |
| topic_facet | psoriasis COVID-19 SARS-CoV-2 systemic therapy biologics inflammatory skin disease Th17 cells adipokines glycoproteins fatty acid-binding protein skin-resident memory T cells human cytokines autoantigens treatment regulatory T cell forkhead box protein 3 short chain fatty acid butyrate interleukin-17A interleukin-23 dendritic cell gut microbiome Janus kinases therapy calcipotriol betamethasone dipropionate long-term treatment nail psoriasis proactive treatment topical therapy scalp psoriasis vitamin D3 derivatives BMDCs IL-23 IL-36γ metformin psoriatic arthritis assessment disease activity composite disease activity measures patient-reported outcomes cross-sectional studies health care surveys Japan treatment goal biological drugs anti-TNF-α anti-IL-17 anti-IL-12/23 adherence persistence early diagnosis early intervention female sex hormone estrogen progesterone thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MN Surgery |
| url | ONIX_20250220_9783725818792_39 |